| Tolerability Comparison of Flarex to Lotemax SM (NCT07588074) | Harrow Inc | 2021-05-01 |
| Biomarkers in Ocular Inflammation and Uveitis (NCT04690829) | National Eye Institute (NEI) | 2020-12-29 |
| Dextenza in the Post-op Management of Vitreoretinal Surgeries (NCT04371445) | The Cleveland Clinic | 2020-06-01 |
| Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic (NCT04374656) | Johns Hopkins University | 2020-05-18 |
| Corneal Epithelial Stem Cells and Dry Eye Disease (NCT03302273) | Sloan W. Rush, MD | 2019-02-01 |
| Effects of Xiidra on Closed Eye Tear Film Leukocytes in Dry Eye Disease (NCT03408015) | University of Alabama at Birmingham | 2019-01-01 |
| KPI-121 1% Versus Prednisolone for the Treatment of Inflammation Following Cataract Surgery in Children (NCT03596723) | Kala Pharmaceuticals, Inc. | 2018-07-03 |
| PGE2 Levels in Patient Treated With NSAIDs (NCT03597867) | University of Trieste | 2018-04-25 |
| Efficacy and Safety of PRO-155 on Inflammation of the Conjunctival Surface in Subjects With Grade I-III Pterygium vs Placebo. (NCT03521791) | Laboratorios Sophia S.A de C.V. | 2017-12-13 |
| LE Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery (NCT02786901) | Bausch & Lomb Incorporated | 2016-06-01 |
| RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD (NCT02128113) | Biogen | 2014-05-31 |
| Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects (NCT01808547) | Sun Pharmaceutical Industries Limited | 2013-05-01 |
| Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection (NCT01721694) | Adapt Produtos Oftalmológicos Ltda. | 2012-12-01 |
| Comparison Study of ISV-303 to DuraSite Vehicle in Cataract Surgery Subjects (NCT01576952) | Sun Pharmaceutical Industries Limited | 2012-07-01 |
| Study to Compare Differing Dosing Regimens of ISV-303 (Bromfenac in DuraSite) to Xibrom and Vehicle in Post Cataract Surgery Volunteers (NCT01190878) | Sun Pharmaceutical Industries Limited | 2010-08-01 |
| Loteprednol Etabonate in an Ophthalmic Base vs Vehicle for the Treatment of Inflammation Following Cataract Surgery (NCT00699153) | Bausch & Lomb Incorporated | 2008-06-01 |
| Loteprednol Etabonate Ophthalmic Ointment vs. Vehicle in the Treatment of Inflammation Following Cataract Surgery (NCT00645671) | Bausch & Lomb Incorporated | 2008-03-01 |
| Triamcinolone Versus Topical Treatment in Post Operative Phacoemulsification (NCT00789971) | Sligo General Hospital | 2007-03-01 |
| Safety and Efficacy Study of rEV131 in the Treatment of Ocular Inflammation After Cataract Surgery (NCT00353964) | Evolutec Group | |